DEMO Not for clinical use until validated. Synthetic data only. No PHI. No live paging.

Demo panel

12 synthetic post-transplant patients · client-side mock data · transparent demo rules · not a clinical system

ID Name POD Tac ALT Cr State
SYNTH-1847 Rivera, A. 96 1.9 68 1.3 FLAG
SYNTH-1102 Nguyen, T. 214 8.4 42 1.1 WATCH
SYNTH-0558 Patel, S. 312 4.9 55 1.6 WATCH
SYNTH-0921 Okonkwo, M. 41 6.9 28 0.9 OK
SYNTH-2001 Chen, L. 18 8.1 35 1.0 OK
SYNTH-0774 Brooks, J. 155 6.2 31 1.2 OK
SYNTH-1310 Hassan, R. 67 7.0 39 1.0 OK
SYNTH-0442 Garcia, E. 289 5.8 33 1.1 OK
SYNTH-1688 Kim, H. 120 6.5 29 0.8 OK
SYNTH-0033 Anders, P. 52 7.4 40 1.0 OK
SYNTH-2219 Diaz, C. 8 9.0 48 1.4 OK
SYNTH-0900 Walsh, K. 401 5.1 27 1.0 OK

FLAG detail — SYNTH-1847 Rivera, A.

Tacrolimus trough trend (demo draws): 3.1 · 2.8 · 2.4 · 2.1 · 1.9

LFTs / renal / CBC (latest): ALT 68 · AST 61 · Cr 1.3 · WBC 4.1

Demo rule (not clinically validated): FLAG if tacrolimus trough declines across ≥3 consecutive draws and latest value is below the demo lower band. This is illustrative logic for product storytelling — not a diagnostic algorithm.

Alert routing log (simulated)

[07:14] SYNTH-1847
FLAG tac trough ↓ 3 draws
→ Pharmacy · Hepatology · Would notify (simulated)
[06:52] SYNTH-1102
WATCH tac above demo upper band
→ Pharmacy · Would notify (simulated)
[06:40] SYNTH-0558
WATCH Cr trending up + mild ALT rise
→ Hepatology · Surgery tagged · Would notify (simulated)
[05:10] panel
OK 9 / 12 nominal on demo rules
→ No route

Protocol checklist — SYNTH-1847

  • ✓ Week 1–4 lab cadence documented
  • ✓ Immunosuppression teaching complete
  • ○ Pharmacy follow-up (due) — demo
  • ○ Month-3 clinic milestone — pending
  • ✓ Coordinator outreach logged

Checklist is demo-only; not connected to real schedules.

P0 guardrails

  • No real PHI
  • No real EHR read/write
  • No autonomous paging of real clinicians
  • No proven outcome claims in product UI